PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsBrucellosis
MeSH D002006 - brucellosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016905:Gram-negative bacterial infections
29 Companies
16 Drugs
$
Success rate
D002006: 
Brucellosis
14 Companies
4 Drugs
$
Success rate
D002007:Bovine brucellosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanRifampin Rifampin  2008-05-22   
Lupin ResearchRifampin Rifampin  2013-08-21   
SanofiRifampin Rifadin  1982-01-01   
Isoniazid, Rifampin Rifamate  1982-01-01   
Isoniazid, Rifampin, Pyrazinamide Rifater  1994-05-31   
Chartwell PharmaceuticalsRifampin Rifampin  2008-03-28   
Hikma PharmaceuticalsRifampin Rifampin  1999-10-29   
Isoniazid, Rifampin Rifampin Isoniazid  2005-07-29   
Epic PharmaRifampin Rifampin  1997-05-28   
Oxford PharmaceuticalsRifampin Rimactane  1982-01-01   
Fresenius KabiRifampin Rifampin  2014-08-21   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Rifampin
Sanofi
Isoniazid,
Pyrazinamide,
Rifampin
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use